Meditation Statistics 2026: What the Data Actually Says
Meditation statistics for 2026: 60.5M Americans meditate, clinical evidence by condition, AI trends, and global figures. Every source verified and cited.
Key things to know before you read.
60.5 million Americans meditate.
Two peer-reviewed analyses of the same CDC data give 17.3% and 18.3%. We explain why both are correct and what the difference means.
Clinical evidence is strong, honest about limits.
MBSR matched an SSRI in a JAMA trial. But the largest school mindfulness study (8,376 students) found no benefit. We show both.
AI therapy is the #1 consumer AI use case.
Headspace Ebb has handled 7M+ messages. But Woebot shut down its consumer app while ChatGPT serves ~1.2M users/week showing signs of crisis.
Three credible sources. Three different answers to “how many Americans meditate.”
The strongest peer-reviewed U.S. estimate says 18.3% of adults used meditation in 2022. That’s about 60.5 million people, up from 7.5% in 2002. A separate analysis of the same federal data puts it at 17.3%. And Pew Research found 38% meditate at least a few times a month.
That gap is the story, not a bug. Meditation has grown so mainstream that the size of the audience depends on whether you’re asking about past-year use, regular frequency, spiritual practice, or app-assisted behavior.
Three credible sources. Three different numbers. The gap between them is the story, not a bug.
The measurement problemMost “meditation statistics” articles pick whichever number sounds most impressive and move on. This one explains why the numbers disagree, which sources you should actually trust, and what the data says about clinical evidence, apps, AI, and the regulatory landscape reshaping the industry.
How many people meditate in 2026?
The honest answer: it depends on how you measure it. Here are the strongest data points, and why they’re all technically correct.
The 17.3% vs. 18.3% question
Two peer-reviewed teams analyzed the same federal dataset (the CDC’s National Health Interview Survey for 2022) and got different numbers. Both are legitimate.
17.3% comes from Nahin, Rhee & Stussman in JAMA (2024), using three NHIS cycles (2002, 2012, 2022). NCCIH adopted this figure for its public-facing fact page.
18.3% (about 60.53 million adults) comes from Davies, Faschinger, Galante & Van Dam in Scientific Reports (2024), using five NHIS cycles (2002, 2007, 2012, 2017, 2022) with different population weighting.
The difference is methodological, not factual. We cite both because reconciling them honestly is the kind of thing no other statistics page does well.
Why two numbers from one dataset?
Nahin et al. used three NHIS survey cycles with one analytical approach. Davies et al. used five cycles with a different population weighting method. Neither is wrong. This is how survey statistics work: reasonable methodological choices produce slightly different estimates. The 17.3% to 18.3% range is the honest answer.
Self-reported frequency polling
A YouGov poll found 34% of U.S. adults meditate weekly or more often: 14% daily, 14% a few times a week, and 6% once a week. That’s nearly double the NHIS figure, though the specific poll’s methodology details are not publicly available.
Why such a large gap? The NHIS asks about past-year use as part of a broader health survey. Frequency polls ask about behavior directly. People who pray meditatively, do breathing exercises, or use mindfulness apps may say “yes” to a frequency question but not think of it as “meditation” in a health survey context.
Spirituality framing
Pew Research’s 2023 spirituality survey found 38% of Americans meditate at least a few times a month, including 22% who mainly do it to feel some kind of connection and 16% who mainly do it for health, enjoyment, or other reasons.
Then in 2025, Pew’s Religious Landscape Study (n=36,908) found 23% of U.S. adults meditate weekly or more often for spiritual reasons, with another 7% doing so monthly.
U.S. meditation adoption over 20 years
NHIS peer-reviewed data, percentage of U.S. adults
Why these numbers don’t contradict each other
| Survey | Figure | What it measures | Year |
|---|---|---|---|
| NHIS (via Scientific Reports) | 18.3% | Past-year meditation use (health context) | 2022 |
| NHIS (via JAMA / NCCIH) | 17.3% | Past-year meditation use (different weighting) | 2022 |
| Pew (spirituality) | 38% | Monthly+ meditation (spiritual + health) | 2023 |
| Pew (religious landscape) | 23% | Weekly+ spiritual meditation | 2025 |
The pattern is clear. Narrow clinical definitions produce smaller numbers. Broader frequency-based or spirituality-inclusive definitions produce larger ones. Neither is wrong. You just need to know what you’re citing.
Who’s meditating now: the demographics that surprise
Here’s the most important finding that no other meditation statistics article covers. Davies et al. (2024) found that meditation growth has accelerated fastest among previously under-represented groups. This directly contradicts the common narrative that meditation is mainly for affluent urban professionals.
Other demographic highlights from federal data:
- Women meditate at roughly double the rate of men: 16.3% vs. 11.8% (Clarke et al., NCHS Data Brief 325, 2018).
- Children 4 to 17: Meditation rose from 0.6% in 2012 to 5.4% in 2017, a ninefold increase and the steepest rise of any mind-body practice among minors (NCHS Data Brief 324, 2018).
- Meditation is now the most popular complementary health approach in the U.S., surpassing yoga (15.8%), chiropractic (11.0%), and massage (10.9%) per NCCIH analysis of 2022 NHIS data. Overall complementary health use rose from 19.2% in 2002 to 36.7% in 2022.
- Among adults not accessing mental health care, meditation growth was significant (OR=1.39), as well as among those with severe psychological distress (OR=1.33). Meditation is reaching people the healthcare system is not.
Curious what personalized meditation actually feels like? StillMind generates sessions based on what you’re going through right now, not a generic category. Try it free.
How the rest of the world meditates.
In India, 234 million people showed up for a single day of yoga. In the UK, 87,000 people could benefit from meditation therapy on the NHS, but only 3,000 get it. Every country tells a different story.
Meditation around the world
No single international survey measures meditation identically across countries, so every cross-country comparison is approximate. That caveat matters. With it in mind, here’s what the strongest national data shows.
United Kingdom
16% of British adults had learned to practice mindfulness by 2021, statistically unchanged from 15% in 2018 (Simonsson et al., PLOS ONE, May 2024). Of those who learned, only 25% maintained regular practice, 32% were occasional, and 43% had stopped entirely. That attrition rate is a useful benchmark for the industry.
The UK’s most important data point may be the access gap. Roughly 3,000 patients receive mindfulness-based cognitive therapy (MBCT) through the NHS annually, while an estimated 87,000 adults at risk of recurrent depression could benefit. That’s a 28-to-1 gap between supply and need.
Germany, France, and the rest of Europe
Germany: 15.1% lifetime meditation prevalence, with 6.6% currently practicing (Cramer et al., 2019, n=2,126). Practitioners reported positive changes especially for mental well-being (71.1%) and mental capacity (50.3%).
France: About 9% practice relaxation, meditation, or sophrology weekly (Statista, 2018). More than a third of French meditators started during the pandemic (Statista, September 2020).
The EU AI Act, which entered into force August 1, 2024, will reshape how meditation apps operate in Europe. More on that in the regulation section.
India, Australia, and Asia-Pacific
India dominates global meditation by sheer scale. International Day of Yoga 2023 drew an estimated 234 million participants (Ministry of AYUSH). The AYUSH sector grew from $18 billion in 2020 to $24 billion in 2023.
Australia: 35% of women aged 28 to 33 and 27% aged 56 to 61 used yoga or meditation (Penman et al., Complementary Therapies in Medicine, 2011, n=19,209). Smiling Mind, Australia’s leading not-for-profit meditation app, reports 9.3 million global downloads and 14 million under-25s supported via its app and school programs (2024 Impact Report).
Japan: No single national meditation prevalence survey exists, but 82.7% of Japanese workers report feeling anxious or stressed about their jobs (Nakano, Frontiers in Psychology, 2025), fueling growing corporate interest in mindfulness research.
The WIN World Survey (2024) offers a broad comparison: over half of respondents in India (79%), Pakistan (56%), Morocco (57%), Malaysia (55%), Mexico (55%), the US (54%), and the Philippines (51%) meditate “at least sometimes.” These figures are directional only; “sometimes” is a broad definition.
Source check
Cross-country comparisons are inherently approximate. Each figure uses different methodology, sample frames, and definitions of "meditation." The WIN figures ("at least sometimes") are the broadest; NHIS ("past-year health use") is the narrowest. No single global prevalence number exists.
Why people meditate now
Meditation is both spiritual and practical. The data makes that clear, even though most industry reporting treats it as purely secular wellness.
The spiritual-practical split
Pew’s 38% monthly+ figure breaks down into two distinct groups: 22% who mainly meditate for connection (spiritual experience, closeness to something greater) and 16% who mainly do it for health, enjoyment, or other reasons.
That split matters. It means more than half of regular meditators approach the practice with at least some spiritual intent. The “meditation is just a productivity hack” narrative misses the majority of practitioners.
Why Americans meditate
Pew Research, 2023 (among those who meditate monthly+)
What older adults say
AARP provides the most detailed motivation breakdown for adults 50+. Among older meditators:
Top reasons for meditating (adults 50+)
AARP survey, 2023 (n=1,128)
Notably, the same AARP survey found 71% of meditators aged 50+ never use a meditation app. The meditation audience is dramatically larger than the meditation-app audience.
The anxiety curve
The context for all this growth: Americans are becoming measurably more anxious. The American Psychiatric Association’s May 2024 poll found 43% of U.S. adults felt more anxious than the prior year, up from 37% in 2023 and 32% in 2022. APA’s Stress in America 2025 report found 62% cite societal division as a major stressor, 54% feel isolated, and 50% feel left out.
The pattern across all these surveys: people start meditating for stress relief but stay for deeper reasons. The practical on-ramp matters, but the spiritual depth keeps people coming back.
Strong for anxiety. Honest about limits.
This is where the article earns or loses credibility. Meditation research is stronger than most wellness categories and weaker than most headlines claim. Here's the honest breakdown.
What the science actually supports
The anchor study
A 2023 randomized clinical trial published in JAMA Psychiatry with 276 adults with anxiety disorders found that 8 weeks of mindfulness-based stress reduction (MBSR) was noninferior to escitalopram (a standard SSRI medication).
Read that carefully. “Noninferior” means “not worse than,” not “better than” or “replaces.” But for a behavioral intervention to match a first-line medication in a rigorous trial is genuinely significant. A 2025 follow-up found that MBSR delivered by videoconference was noninferior to in-person MBSR, but not noninferior to escitalopram via videoconference, so the result has some delivery-mode nuance. For practical approaches, see meditation for anxiety.
The evidence by condition
The most comprehensive synthesis: Goldberg et al. (Perspectives on Psychological Science, 2022) analyzed 44 meta-analyses of mindfulness-based intervention RCTs. Effect sizes ranged from d=0.10 (youth) to d=0.89 (anxiety disorders). MBIs were superior to specific active controls for depression, substance use, smoking, pain, and psychiatric symptoms with small effects.
| Condition | Key finding | Source | Strength |
|---|---|---|---|
| Anxiety disorders | MBSR noninferior to escitalopram; ~1.35-point CGI-S drop | Hoge 2023, JAMA Psychiatry | Strong |
| Depression relapse | MBCT hazard ratio 0.69 vs. control (IPD meta-analysis, n=1,258) | Kuyken 2016, JAMA Psychiatry | Strong |
| Depression (head-to-head) | MBCT roughly equivalent to maintenance antidepressants (44% vs. 47% relapse at 24 months) | Kuyken 2015, Lancet | Strong |
| PTSD (veterans) | MBSR > present-centered group therapy; "modest" effect | Polusny 2015, JAMA | Moderate |
| Chronic low back pain | MBSR 60.5% vs. CBT 57.7% vs. usual care 44.1% improved at 26 weeks | Cherkin 2016, JAMA | Moderate |
| Insomnia | Mindful awareness outperformed sleep hygiene by ~2.8 points on PSQI | Black 2015, JAMA Internal Medicine | Moderate |
| Substance use | MBRP > treatment-as-usual at 12-month follow-up | Bowen 2014, JAMA Psychiatry | Moderate |
| Blood pressure | Only TM rated Class IIB; MBSR rated Class III (no benefit) | AHA 2013 statement (Brook et al.) | Weak/null |
App-delivered meditation has its own evidence base. Linardon et al. (2024, Clinical Psychology Review, 45 RCTs) found Hedges’ g=0.24 for depression and g=0.28 for anxiety vs. controls. One standout: a Calm app RCT by Huberty (2022) showed d=0.32 for depression, d=0.23 for anxiety, and d=0.94 for insomnia, the largest single effect size in the consumer app literature. For sleep-specific approaches, see meditation for sleep.
What the evidence doesn’t support yet
This section belongs in any honest reference piece.
87% of mindfulness RCTs report positive results. That's implausibly high.
Coronado-Montoya et al., PLOS ONE, 2016The MYRIAD trial is the largest and most important null result in the field. Kuyken et al. (Evidence-Based Mental Health, 2022) studied 85 UK schools, 8,376 students, and 28,000+ children over 8 years. Universal school-based mindfulness did not outperform teaching-as-usual on pupil mental health. Critically, 80% of pupils did not complete the required mindfulness homework. The intervention failed not because mindfulness doesn’t work, but because universal delivery at scale couldn’t produce adherence.
Conflict of interest in app research. O’Daffer et al. (JMIR Mental Health, 2022) reviewed 14 Headspace and 1 Calm RCT and found 50% reported conflicts of interest with the app company. Studies were “generally underpowered to detect ‘small’ or ‘medium’ effect sizes.” This doesn’t invalidate the findings, but it should inform how you weight them.
Adverse effects deserve more precision. Farias et al. (2020, Acta Psychiatrica Scandinavica) reported a pooled adverse-event prevalence of 8.3%, but this masks a huge methodological gap: 3.7% in experimental RCTs vs. 33.2% in observational studies. Britton et al. (2021) showed adverse-event rates range from less than 1% with passive monitoring to 67-73% when researchers actively ask about them. The rate depends on how hard you look. Lindahl et al. (2017) identified over 50 types of meditation-related challenges across 7 domains, with some practitioners reporting functional impairment lasting days to years.
Publication bias. Van Dam et al. (2018, “Mind the Hype,” Perspectives on Psychological Science) warned that “misinformation and poor methodology associated with past studies of mindfulness may lead public consumers to be harmed, misled, and disappointed.”
Source check
Including negative and null results is not anti-meditation. It's anti-hype. The strongest evidence supports meditation for anxiety, depression relapse prevention, and sleep. Claims about blood pressure, universal school delivery, and dramatic cognitive enhancement are weaker than the headlines suggest. Any statistics page that presents only positive outcomes is marketing, not reporting.
Meditation apps: scale, downloads, and why the market-size numbers are messy
Downloads and reported scale
The leading meditation apps report impressive numbers. These are self-reported company disclosures, not audited active-user counts.
| App | Claimed scale | What it means |
|---|---|---|
| Calm | 150M+ downloads | Lifetime downloads across all platforms (per company reports) |
| Headspace | ”Touched 100M+ lives” | Self-reported marketing language (not audited downloads) |
| Insight Timer | 32M members | Registered accounts (January 2026 press release), 20K teachers, 300K+ titles |
| Waking Up | Not disclosed | ~$1.20M monthly in-app revenue |
| Balance | Not disclosed | Personalization-first approach; 2022 Apple App of the Year |
Downloads are not active users. Someone who downloaded Calm in 2018, used it once, and deleted it counts toward that figure. These numbers tell you about brand reach, not about sustained engagement.
Most meditators are not app users
Pew’s June 2023 survey on apps and websites in religious life found that 22% of adults under 50, 16% of adults 50 to 64, and 9% of adults 65+ “use apps or sites to help them meditate.” Usage declines sharply with age, but even among younger adults, nearly 4 in 5 don’t use an app.
Among adults 50+ who meditate, 71% say they never use a meditation app (AARP, 2023). The meditation audience is dramatically larger than the meditation-app audience.
Who’s earning what
In-app purchase revenue gives a clearer picture of sustained engagement than downloads. These are January 2024 figures from Sensor Tower via Statista:
| App | Monthly IAP revenue | Context |
|---|---|---|
| Calm | $7.68M | Market leader; launched standalone Calm Sleep app Sept 2025 |
| Headspace | $4.02M | 4,000+ enterprise partners incl. Starbucks, Adobe, Delta |
| Sleep Cycle | $1.36M | Sleep-first positioning |
| BetterSleep | $1.22M | Formerly Relax Melodies |
| Waking Up | $1.20M | Sam Harris; philosophy-forward approach |
| Insight Timer | $1.11M | Largest free library; teacher marketplace model |
The market-size vendors disagree. Wildly.
Different research firms value the meditation app market very differently, and the reason is taxonomy. “Mindfulness meditation apps” is a much narrower category than “meditation management apps,” which may include sleep tools, breathwork, and broader wellness platforms.
Subscription economics
The open benchmarks come from RevenueCat’s State of Subscription Apps 2026 report for the broader Health & Fitness category:
Note: a commonly cited “37.3% trial-to-paid conversion” figure is the cross-category median (down from 40.5% in the prior year), not a Health & Fitness figure. The category-specific number is much lower.
Industry context
Headspace Health (formed via the Headspace and Ginger merger in August 2021 at roughly $3 billion valuation) has gone through multiple layoff rounds: December 2022 (roughly 4%), June 2023 (15%, including 33 therapists), and November 2024 (about 13%). Tom Pickett, formerly DoorDash’s CRO, succeeded Russell Glass as CEO in 2024.
Ten Percent Happier rebranded as Happier in September 2024. Co-founder Dan Harris departed citing “creative, financial, and interpersonal differences,” taking full ownership of the podcast in March 2025.
Calm’s last external valuation was $2 billion (Series C, December 2020). Revenue estimates range from $227 million (Sacra) to $596 million (Getlatka) for 2024, a disagreement that itself illustrates the opacity of private meditation-app financials. Calm Health, its B2B arm, reportedly covers 39 million lives (Sacra, January 2026).
Digital health funding context: Rock Health’s 2025 report found U.S. digital health funding hit $14.2 billion across 482 deals, a 35% increase over 2024 and the highest since 2022, with 26 mega deals and 15 new unicorns.
Therapy is the #1 consumer AI use case.
Meditation apps now compete with ChatGPT, not just each other. The products are shipping. The users are engaging. The safety evidence is still catching up.
AI and meditation: what’s already real, what’s still uncertain
The macro shift
Harvard Business Review’s April 2025 analysis (drawing on Filtered’s Top-100 Gen AI Use Case Report) ranks “therapy/companionship” as the #1 use case for consumer generative AI in 2025, up from #2 in 2024. This reframes the competitive landscape: meditation apps are competing not only with each other but with general-purpose AI that hundreds of millions of people already use for emotional support.
OpenAI reports that GPT-5 reduced problematic responses in suicide conversations by 52% vs. the prior version, and that the company consulted 170+ mental-health experts across 60 countries. The scale of the problem is unprecedented: purpose-built wellness apps serve a fraction of those users and face stricter scrutiny.
Safety research
Stanford’s Moore et al. (FAccT ‘25) evaluated five therapy chatbots and found that LLMs express stigma toward mental-health conditions (especially schizophrenia and alcohol dependence) and respond inappropriately in critical scenarios. One bot volunteered specific high bridges to a user signaling veiled suicidal intent. Senior author Nick Haber: “LLMs potentially have a really powerful future in therapy, but we need to think critically about precisely what this role should be.”
The APA Health Advisory (November 2025) was blunt: “While chatbots seem readily available to offer users support and validation, the ability of these tools to safely guide someone experiencing crisis is limited and unpredictable.”
Woebot, Character.AI, and the regulatory asymmetry
Woebot Health shut down its direct-to-consumer app on June 30, 2025 (data anonymized by July 31). Founder Alison Darcy cited “the cost and challenge of fulfilling the FDA’s requirements for marketing authorization.” This is the starkest signal in the space: a purpose-built, clinically-informed AI mental-health startup couldn’t clear the regulatory bar that general-purpose LLMs face no equivalent of.
Woebot shut down its consumer app. ChatGPT didn't. That's the whole story of AI mental health in 2025.
The regulatory asymmetryCharacter.AI faces multiple lawsuits. Garcia v. Character Technologies (filed October 2024, regarding 14-year-old Sewell Setzer III’s February 2024 suicide) survived a First Amendment challenge in May 2025, with a federal judge ruling the chatbot output was a “product, not speech.” The Peralta family filed a second wrongful-death suit in September 2025. Google and Character.AI reached a settlement in January 2026.
What’s already in production
Headspace says members have exchanged more than 7 million messages with its AI companion Ebb (up from 1 million in early 2025), and 64% of surveyed users reported feeling heard and understood. Ebb is now deployed by more than 2,000 employers and available in the UK, Canada, and Australia. For a detailed comparison, see our best AI meditation apps guide.
StillMind generates entire meditation sessions in real time based on what you type. It’s a fundamentally different approach from pre-recorded libraries, and it represents where the industry is heading: from content selection to content generation.
Other notable entrants: TRIPP’s Kokua is an AI emotional-support companion on Apple Vision Pro (won the 2025 Aurea Award for Innovation). Mindvalley launched the first immersive meditation app on visionOS in February 2024. A December 2025 medRxiv preprint reports a 3-arm RCT (n=200) of the Lumen AI Voice Coach delivering problem-solving therapy for moderate depression and anxiety, the first larger-scale test of AI voice-delivered therapy (not yet peer-reviewed).
AI can sound human, but trust still favors humans
A 2025 study published in Scientific Reports (n=143) found that trained AI voices produce evaluations “indistinguishable from human mindfulness exercises” in a categorization task.
But a 2026 follow-up (n=411, Internet Interventions) found the opposite dynamic at the belief level: acceptance and perceived effects were significantly higher when people believed the exercise was human-created rather than AI-generated. The labeling effect (measured at partial eta-squared of 0.10 for acceptance and 0.34 for experienced effects) swamped the voice-quality finding.
Together: AI can deliver the experience acoustically. But the label still matters. Transparency about what’s AI-generated may be not just ethical but experiential.
Market readiness
A 2026 Bipartisan Policy Center survey (n=1,000 registered voters) found about 3 in 10 U.S. adults have used a self-guided digital mental-health or wellbeing tool. Among those users:
Digital mental health tool adoption
Bipartisan Policy Center, 2026 (among U.S. adults who used digital tools)
A counterintuitive finding: rural users were the least likely to use digital mental health tools, but the most likely to find them “totally helpful” (94% vs. 86% in other areas).
Source check
AI meditation is advancing faster than trust, and trust is advancing faster than regulation. The studies cited here measure acceptance and perceived effectiveness, not clinical outcomes. Nobody has published a head-to-head RCT comparing AI-led meditation with human-led meditation for anxiety or depression. That study hasn't been done yet.
Regulation, privacy, and the trust question
The EU AI Act timeline
The EU AI Act (Regulation EU 2024/1689) entered into force on August 1, 2024, with staggered applicability dates:
Emotion-recognition AI in the workplace and education is already prohibited under Article 5 (in force since February 2025). Mental-health AI may qualify as “high-risk” under Annex III, triggering conformity assessments. Meditation apps that use AI to personalize content or present chatbot-like features will need to be transparent about when users are interacting with AI.
U.S. state legislation is accelerating
Illinois Public Act 104-0054 (signed August 1, 2025 by Governor Pritzker) is the first state statute to explicitly prohibit AI from providing professional therapy services or making therapeutic decisions without licensed-professional review.
Utah HB 452 (signed March 25, 2025) requires clear disclosure that mental-health chatbots are AI: before first access, after 7 days of non-use, and whenever users ask. Fines up to $2,500 per violation.
The Future of Privacy Forum’s 2026 tracker counts 98 chatbot-specific bills across 34 states, plus 3 federal proposals. The split is notably bipartisan: 53% Democratic, 46% Republican.
FDA-cleared digital therapeutics
A parallel regulatory track is emerging for prescription digital treatments:
- Rejoyn (April 2024): first FDA-authorized prescription DTx for major depressive disorder.
- DaylightRx (September 2024): first FDA-cleared digital treatment for generalized anxiety disorder.
- SleepioRx (August 2024): FDA-cleared for insomnia.
- CMS 2025 Medicare coverage (effective January 1): three new HCPCS codes (G0552, G0553, G0554) for FDA-cleared prescription digital mental-health treatments. Reimbursement at roughly $20 for the first 20 minutes of supervision. Cigna extended coverage to FDA-approved digital therapeutics in September 2025.
These are not meditation apps, but they establish a regulatory pathway that meditation apps will eventually intersect.
Privacy enforcement
The FTC has made mental-health data privacy a priority. BetterHelp paid $7.8 million in 2023 for sharing email, IP, and questionnaire data with Facebook, Snapchat, Criteo, and Pinterest. Cerebral paid $7.8 million in 2024 for sharing sensitive mental-health data without adequate authorization. Mozilla’s Privacy Not Included project reviewed 32 mental-health and meditation apps and gave 28 of them warning labels. Six apps (including Calm and Woebot) subsequently improved their practices.
Source check
Privacy enforcement is accelerating. The FTC's actions set the precedent that sharing mental-health data without adequate authorization has a price. For meditation apps that personalize content using AI, the convergence of EU regulation, U.S. state legislation, and federal enforcement is reshaping what's possible.
Apple’s on-device approach sets a new standard. Apple’s Foundation Models framework processes data on-device, works offline, and does not use users’ private personal data or interactions for training. For meditation apps that build on this framework, including StillMind, it means AI personalization without data leaving the device.
Workplace, schools, and healthcare integration
Corporate wellness
This is the strongest employer-wellness statistic currently available and eclipses the more commonly cited (but less well-sourced) figures from older surveys.
The research supports the investment. Bartlett et al. (Journal of Occupational Health Psychology, 2019, 23 RCTs) found workplace mindfulness programs produced meaningful effect sizes:
Vonderlin et al. (Mindfulness, 2020, 56 studies, n=5,161) confirmed small-to-large reductions in stress, burnout, and distress, along with improvements in job satisfaction.
Schools
83% of K-12 principals reported using a social-emotional learning (SEL) curriculum in 2023-24 (CASEL/RAND, April 2024), up from 76% in 2021-22. SEL is adjacent to, not synonymous with, mindfulness, but the overlap is substantial.
The caveat is critical. As covered in the clinical evidence section, the MYRIAD trial (the largest school mindfulness study ever conducted) found universal mindfulness training did not outperform teaching-as-usual:
80% of pupils did not complete the required mindfulness practice homework.
MYRIAD trial, 2022 (n=8,376 across 85 UK schools)This doesn’t mean school mindfulness can’t work. It means universal delivery without ensuring adherence doesn’t produce measurable outcomes at scale. Targeted, well-implemented programs may fare differently.
Veterans and healthcare
Polusny et al. (JAMA, 2015, n=116) found MBSR produced significantly greater PTSD symptom reduction than present-centered group therapy among veterans, though the effect was described as “modest.” The VA distributes free apps including Mindfulness Coach, PTSD Coach, and CBT-i Coach.
Wearables, VR, breathwork, and the optimization backlash.
The edges of the meditation industry in 2026: hardware that reads your brain, virtual environments that surround you, a breathing technique that outperformed meditation in a head-to-head trial, and a cultural moment that questions whether we've gone too far.
The 2026 frontier
Wearables at scale
Oura has sold more than 5.5 million rings, with paying subscribers doubling to 2 million in 2024. Revenue tracked roughly $500 million in 2024 and toward $1 billion in 2025, with an October 2025 valuation of $11 billion (Sacra). Smart-ring shipments are projected to grow 49% in 2025 vs. just 6% for smartwatches (IDC, Bloomberg, January 2026). Oura integrated with Headspace in 2023.
Muse S Athena (March 2025) is the first consumer-grade headband combining EEG and fNIRS (functional near-infrared spectroscopy). The meditation-wearable category is maturing from novelty to scientific instrument.
Apple Watch expanded its Mindfulness app (formerly Breathe) in watchOS 10 with Reflect prompts and State of Mind logging. Fitness+ Audio Meditations are now a subscriber feature.
VR meditation
TRIPP has logged 14 million “mindful minutes” and delivered roughly 6 million wellness sessions from 2019 to 2022. Of its monthly active users, 43% open TRIPP 2 to 3 times per week. The company has raised $26.3 million (BITKRAFT, Amazon Alexa Fund, Qualcomm, HTC, Niantic). Stanford’s Bailenson published a 2025 review in Nature Human Behaviour concluding that “the benefit of being there depends on the activity,” with VR uniquely effective for immersion-first practices. The VR wellness market is estimated at roughly $500 million in 2025 with a projected 25% CAGR.
Breathwork’s landmark study
Five minutes per day of cyclic sighing produced greater mood improvement than mindfulness meditation over one month.
That finding comes from Balban et al. (Cell Reports Medicine, January 2023), a Stanford-affiliated RCT that is the breathwork field’s most important study to date. It has propelled interest in cyclic sighing, Wim Hof techniques, and apps like Othership, Breathwrk, and Open.
Sleep
Calm Sleep Stories have been played more than 1 billion times (September 2025 ten-year mark), with 50 billion minutes listened across all sleep content. Calm launched a standalone Calm Sleep app on September 16, 2025, its first new direct-to-consumer product since the flagship. Hilton partnered with Calm in November 2025 to bring Sleep Stories to in-room TVs across 9,100+ properties.
Psychedelics intersection
The FDA rejected Lykos Therapeutics’ MDMA-assisted PTSD therapy on August 9, 2024. Lykos cut 75% of staff and rebranded as Resilient Pharmaceuticals. Oregon’s psilocybin services have treated roughly 16,000 clients since launch in 2023, generating $1.7 million in total revenue, but a January 2026 investigation found roughly one-third of licensed service centers had closed. RAND’s January 2026 survey estimated approximately 9.55 million U.S. adults (3.7%) microdosed psilocybin, LSD, or MDMA in 2025.
The optimization backlash
The Global Wellness Summit’s 2026 lead trend is “The Over-Optimization Backlash,” framing wellness as shifting from “measurement to meaning, catharsis over clinical data.” Oxford’s 2022 Word of the Year, “goblin mode” (93% of 340,000 votes), signaled consumer exhaustion with optimization aesthetics.
McKinsey’s Future of Wellness 2025 report found Gen Z represents 36% of adults but 41% of wellness spending. Their combination of outsized spending power and high openness to therapy is the market thesis underneath every AI mental-health pitch deck.
Methodology, glossary, and what to watch
How we source this article
This article uses a four-tier source hierarchy:
- Peer-reviewed journals and government data (NHIS, CDC/NCHS, NIH/NCCIH, FDA, WHO): highest confidence. These are the numbers we state without hedging.
- Established polling and think tanks (Pew Research, APA, YouGov, AARP, RevenueCat, Rock Health, Bipartisan Policy Center): strong confidence. Methodology is disclosed and samples are large.
- Market research firms (Grand View, ResearchAndMarkets, Straits, Statista, Fact.MR): directional only. Always cited with the firm name and the specific category definition, since these can vary by 48x for the “same” market.
- Corporate self-reports (Calm, Headspace, Insight Timer, Oura, TRIPP): always labeled as “per company reports” or “self-reported.” Download counts and user figures are not audited.
Every company-reported figure is labeled as such. When peer-reviewed sources disagree (as with the 17.3% vs. 18.3% NHIS analyses), both are cited with the methodological difference explained.
Glossary
- MBSR: Mindfulness-Based Stress Reduction. 8-week program developed by Jon Kabat-Zinn.
- MBCT: Mindfulness-Based Cognitive Therapy. Combines MBSR with CBT for depression relapse prevention.
- MBRP: Mindfulness-Based Relapse Prevention. For substance use disorders.
- DTx: Digital therapeutics. FDA-cleared software-based treatments.
- SaMD: Software as a Medical Device. FDA regulatory category.
- NHIS: National Health Interview Survey. CDC’s annual household survey, the gold standard for U.S. health behavior data.
- RCT: Randomized controlled trial. The strongest study design for causal claims.
- NNT: Number needed to treat. How many people must receive an intervention for one additional person to benefit.
- CAGR: Compound annual growth rate. Common in market-size projections.
What to watch in 2027
- EU AI Act bulk applicability (August 2026) will force transparency requirements on meditation apps with AI features. Watch for compliance-driven product changes.
- FDA-cleared meditation-adjacent DTx: as more digital therapeutics clear the FDA for anxiety, depression, and insomnia, the line between “wellness app” and “medical device” will blur.
- The first AI-vs-human meditation RCT: no head-to-head clinical trial yet exists. Whoever publishes it first will define the conversation.
- Wearable-meditation integration: as EEG and fNIRS headbands become consumer-grade, real-time biofeedback during meditation will move from lab curiosity to product feature.
- Insurance coverage of digital therapeutics: as CMS and private insurers expand coverage of FDA-cleared DTx, reimbursement pathways may reshape the meditation app business model.
About this article
This article uses a four-tier source hierarchy: peer-reviewed journals and government data, then established polling and think tanks, then industry analysts, then corporate self-reports. Every company-reported figure is labeled as such. Compiled by the StillMind editorial team. Last updated April 2026.
Bottom line: what the data actually tells us
Here’s the honest version.
Meditation is widespread. Somewhere between 60 million and 100+ million Americans do it in some form, depending on how you define it. The practice more than doubled in measured prevalence over two decades, and the fastest growth is now among seniors, people with lower education, and those outside the mental-health care system. It’s not just for affluent urban professionals. It never was, and the data now proves it.
The strongest clinical evidence supports meditation for anxiety (where MBSR matched an SSRI in a rigorous trial), depression relapse prevention, and sleep. But the field has real problems: publication bias, conflicts of interest in app research, and the largest school mindfulness study ever conducted finding no benefit. About 8% of participants in research studies experience negative effects. Being honest about these limits is what makes the positive evidence credible.
AI therapy is now the #1 consumer AI use case. Headspace’s Ebb has handled 7 million messages. But Woebot shut down its consumer app, ChatGPT serves over a million people per week showing crisis indicators, and 98 state bills are trying to figure out what the rules should be. The regulatory landscape is moving fast.
That’s where things stand. Not as neat as a listicle, but a lot more useful for anyone trying to make sense of the data.
Ready to try meditation that’s built around you? StillMind combines AI-guided meditation, an encrypted journal, and a free meditation timer. Privacy-first, no data sold. Download free.
FAQ
How many Americans meditate?
It depends on how you measure. The strongest peer-reviewed benchmark (NHIS data, published in Scientific Reports 2024) puts U.S. adult meditation use at 18.3% in 2022, or about 60.5 million people. A separate NCCIH-cited analysis of the same data gives 17.3%. The difference is methodological, not factual. Pew Research's 2023 spirituality survey found 38% meditate at least a few times a month. These aren't contradictory: they measure different aspects of the practice (past-year health use vs. weekly frequency vs. spiritual/wellness practice).
Is meditation scientifically proven?
For anxiety, yes. A 2023 JAMA Psychiatry RCT found 8 weeks of MBSR was noninferior to escitalopram (a standard SSRI) for anxiety disorders. Evidence is also strong for depression relapse prevention (MBCT HR 0.69) and decent for sleep and chronic pain. For broader claims (blood pressure, cognitive enhancement, universal school delivery), the evidence is weaker. The AHA rates MBSR as Class III (no benefit) for blood pressure, and the largest school mindfulness study (8,376 students) found no benefit. About 8.3% of research participants experience adverse effects, though this rate varies enormously by monitoring method.
How does meditation compare to medication for anxiety?
The best evidence comes from Hoge et al. (2023, JAMA Psychiatry, n=276): 8 weeks of MBSR was noninferior to 10 to 20 mg of escitalopram for anxiety disorders. Both groups showed roughly a 1.35-point reduction on the CGI-S scale. "Noninferior" means "not worse than," not "better than" or "replaces." A 2025 follow-up found video-delivered MBSR was noninferior to in-person MBSR but not to video-delivered escitalopram. Meditation and medication are not mutually exclusive, and the best approach depends on individual circumstances.
Do meditation apps work?
Some do, for some people. A 2024 meta-analysis of 45 RCTs (Linardon et al.) found app-delivered meditation produces effect sizes of g=0.24 for depression and g=0.28 for anxiety. A Calm app RCT showed d=0.94 for insomnia, the largest effect in the consumer app literature. But half of Headspace and Calm RCTs have reported conflicts of interest with the app company (O'Daffer et al., 2022). Pew data shows only 22% of adults under 50 and 9% of adults 65+ use meditation apps. Apps are one delivery mechanism, not a prerequisite for effective meditation.
How big is the meditation app market?
It depends on who you ask and what they include. Estimates range from $118.8 million (ResearchAndMarkets, "mindfulness meditation apps") to $5.72 billion (Statista, broader definition). That 48x gap is a taxonomy problem, not a rounding error. Other estimates: Fact.MR $646M, Straits $1.6B, Grand View Research $2.20B. All agree on strong growth. None should be cited as "the" market size without explaining which definition is being used.
Are AI meditation apps replacing human teachers?
Not in a simple replacement sense. AI meditation tools are shipping (Headspace's Ebb has handled 7M+ messages, StillMind generates personalized sessions in real time), and consumer readiness is real (about 70% of digital mental health tool users say they prefer digital to in-person). But a 2026 study found that people rate meditation exercises significantly higher when they believe they were created by humans (Diel et al., Internet Interventions, n=411). Meanwhile, Woebot shut down its consumer app citing FDA regulatory costs, while general-purpose AI like ChatGPT faces no equivalent bar. AI is expanding access, not eliminating the role of human guidance.
Is AI therapy safe?
The evidence is mixed and evolving rapidly. Stanford researchers (Moore et al., FAccT '25) found therapy chatbots express stigma toward certain conditions and respond inappropriately in crisis scenarios. The APA's November 2025 advisory warned that chatbots' ability to "safely guide someone experiencing crisis is limited and unpredictable." OpenAI disclosed that approximately 1.2 million weekly ChatGPT users show indicators of suicidal planning. Character.AI faces multiple lawsuits related to youth safety. At the same time, regulated tools like Wysa (used by 117,000+ NHS patients) show promise with proper guardrails. The key factor is whether the tool is purpose-built with safety monitoring or a general-purpose chatbot repurposed for emotional support.
Is meditation spiritual or secular?
Both. Pew's 2023 data shows 22% of monthly+ meditators do it mainly for spiritual connection, while 16% do it mainly for health or enjoyment. Pew's 2025 data found 23% of U.S. adults meditate weekly+ specifically for spiritual reasons. The "meditation is just a productivity hack" framing misses more than half the practitioners. The practice is both spiritual and practical, and many people experience it as both simultaneously.
Can meditation have negative effects?
Yes. Farias et al. (2020) found a pooled adverse-effect prevalence of 8.3%, but this varies enormously: 3.7% in controlled experiments vs. 33.2% in observational studies. Britton et al. (2021) showed rates range from less than 1% with passive monitoring to 67-73% when researchers actively ask. Reported effects include increased anxiety, depersonalization, and emotional disturbance. Lindahl et al. (2017) identified over 50 types of meditation-related challenges. These are more common in intensive retreat settings and among people with trauma histories. Meditation is not dangerous for most people, but "always safe and beneficial" is not accurate.
Do schools teach meditation?
Increasingly, though usually under the banner of social-emotional learning (SEL) rather than meditation specifically. CASEL/RAND found 83% of K-12 principals reported using an SEL curriculum in 2023-24. However, the MYRIAD trial (85 UK schools, 8,376 students) found universal school-based mindfulness did not outperform teaching-as-usual, largely because 80% of students didn't complete the homework. Targeted programs may work better than universal ones, but the evidence for school-wide mindfulness mandates is currently weak.
How many people meditate globally?
No single global figure exists because every country measures differently. The WIN World Survey (2024) found over half of respondents in India (79%), US (54%), Mexico (55%), and Philippines (51%) meditate "at least sometimes," but this is an extremely broad definition. Stricter national data: US 18.3% past-year (NHIS 2022), UK 16% ever learned mindfulness (Simonsson, 2024), Germany 15.1% lifetime prevalence (Cramer, 2019), France 9% weekly (Statista, 2018). India's scale dwarfs all others, with an estimated 234 million participating in International Day of Yoga 2023.
Try StillMind, free.
AI-guided meditation personalized to exactly what you're dealing with. Works offline. Private by default.